# Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging

> **NCT00612326** · — · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 26 (actual)

## Conditions studied

- Bladder Cancer
- Transitional Cell Carcinoma

## Interventions

- **PROCEDURE:** MRI and PET scanning procedures

## Key facts

- **NCT ID:** NCT00612326
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2015-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00612326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00612326, "Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00612326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*